我们还是挺期待的有药给这样的病人试用，一个是感觉它和激素和骁悉一块联用

We are still looking forward to having the medicine to try on such patients. One is that after it is used in combination with hormones and Xiaoxi, the patient's remission rate and response rate have been significantly increased, and the recurrence rate has been significantly reduced. This is very important. it is good. The second is that there are relatively few adverse reactions, and the amount of hormone reduction is relatively small, so we are still looking forward to these points.

We are still quite looking forward to the drug to such a patient trial, one is to feel that it and hormones and know a piece of use, the patient's remission rate, response rate significantly increased, and the recurrence rate significantly reduced, which is very good. The second is the relative adverse reactions are also very few, the amount of hormone reduction is relatively small, so on these points we are still more looking forward to.

The response rate of the patients is obviously reduced by the combination of MMT and MMT. The second is that relatively few adverse reactions, the amount of hormone reduction is relatively small, so we are still looking forward to these points.<br>